Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Singapore Institute of Advanced Medicine Holdings Ltd. ( (SG:9G2) ) is now available.
Singapore Institute of Advanced Medicine Holdings Ltd. has announced changes to its board and board committee composition effective 9 February 2026, following the retirement of Non-Executive and Non-Independent Director Vivienne Cheng Chi Fan, who will also step down from the Nominating and Remuneration Committees. Her departure leaves both committees with fewer than the required three members, and the company is reviewing its governance structure with a commitment to fill the vacancies within two to three months, underscoring an ongoing adjustment period in its corporate oversight while the remaining directors and audit committee composition remain in place.
The most recent analyst rating on (SG:9G2) stock is a Hold with a S$0.05 price target. To see the full list of analyst forecasts on Singapore Institute of Advanced Medicine Holdings Ltd. stock, see the SG:9G2 Stock Forecast page.
More about Singapore Institute of Advanced Medicine Holdings Ltd.
Singapore Institute of Advanced Medicine Holdings Ltd. is a Singapore-based healthcare group focused on advanced medical services, operating through its subsidiaries to provide specialised clinical care and related healthcare offerings to patients in the region.
Average Trading Volume: 5,489,985
Technical Sentiment Signal: Sell
Current Market Cap: S$64.04M
See more insights into 9G2 stock on TipRanks’ Stock Analysis page.